FrancophonIA/ELRC3.0 huggingface dataset:
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Vizamyl, including the appropriate precautions to be followed by healthcare professionals and patients.
Estonian: Selle alusel lisati Vizamyli omaduste kokkuvõttesse ja pakendi infolehele ravimi ohutusteave, kus on ka tervishoiuspetsialistide ja patsientide võetavad meetmed.
English: At the end of the study, 68 had autopsies carried out on them to prove conclusively whether or not they had significant amounts of β-amyloid plaques in their brains.
Estonian: Uuringu lõpus tehti 68 patsiendil lahang, et tõendada lõplikult, kas nende ajus oli olulisel arvul beetaamüloidnaaste.
English: When the results of the autopsies were compared with the PET scans, the scans were shown to have a sensitivity between 81-93%.
Estonian: Lahangutulemuste võrdlemisel PET-uuringutega selgus, et uuringute tundlikkus oli 8193%.
English: Vizamyl delivers a very low amount of radiation which poses a very low risk of cancer or any hereditary abnormalities.
Estonian: Vizamyli kiirituse kogus on väga väike ja minimaalse vähi- või mis tahes pärilike kõrvalekallete riskiga.
English: Vizamyl was investigated in one main study in 176 patients nearing the end of their lives who had consented to autopsies when they died, in order to prove conclusively whether or not they had significant amounts of β-amyloid plaques in their brains.
Estonian: Vizamyli uuriti ühes põhiuuringus, kus osales 176 kõrges eas patsienti, kes olid andnud nõusoleku surmajärgseks lahkamiseks, et teha lõplikult kindlaks, kas nende ajus on suures koguses beetaamüloidnaaste.
English: How does Vizamyl work?
Estonian: Kuidas Vizamyl toimib?
English: Vizamyl is available as a solution that is given by injection into a vein, about 90 minutes before obtaining an image from a PET scan.
Estonian: Vizamyli turustatakse lahusena, mida süstitakse veeni umbes 90 minutit enne PET-kujutise tegemist.
English: The active substance in Vizamyl, flutemetamol (18F), is a radiopharmaceutical that emits low amounts of radiation and works by targeting and attaching to β-amyloid plaques in the brain.
Estonian: Vizamyli toimeaine flutemetamool (18F) on radiofarmatseutiline ravim, mis emiteerib väikeses koguses kiirgust ja kinnitub ajus olevatele beeta-amüloidnaastudele.
English: However, a positive scan on its own is not sufficient to make a diagnosis in patients with memory problems, as plaques may be seen in patients with different types of dementias as well as in older people with no symptoms.
Estonian: Siiski ei piisa positiivsest tulemusest mäluhäiretega patsiendi diagnoosimiseks, sest naaste võib esineda eri tüüpi dementsuste korral ja samuti mõnel sümptomiteta eakal.
English: For more information about treatment with Vizamyl, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Estonian: Kui vajate Vizamyliga toimuva ravi kohta lisateavet, lugege palun pakendi infolehte (mis on samuti Euroopa avaliku hindamisaruande osa) või pöörduge oma arsti või apteekri poole.
English: What benefits of Vizamyl have been shown in studies?
Estonian: Milles seisneb uuringute põhjal Vizamyli kasulikkus?
English: The Committee noted that PET scans with Vizamyl have a high sensitivity and specificity for detecting a significant amount of beta-amyloid plaques in the brain, and that scans closely reflect what was seen at autopsy.
Estonian: Komitee märkis, et Vizamyliga tehtud PETuuringute tundlikkus ja spetsiifilisus olulise koguse beeta-amüloidnaastude tuvastamiseks ajus on väga suur ning uuringute ja lahangute tulemused on väga sarnased.
English: Vizamyl is used during brain scans in patients with memory problems so that doctors can see whether or not they have significant amounts of β‑amyloid plaques in the brain.
Estonian: Vizamyli kasutatakse mäluprobleemidega täiskasvanud patsientide aju kihtülesvõtete tegemiseks, et arstid saaksid kontrollida beeta-amüloidnaastude olemasolu ajus.
English: How is Vizamyl used?
Estonian: Kuidas Vizamyli kasutatakse?
English: After the image is obtained, it is read by nuclear medicine physicians specifically trained in interpreting PET scans with Vizamyl.
Estonian: Pärast kujutise saamist hindab seda nukleaarmeditsiini arst, kes on saanud Vizamyli PET-kihtülesvõtete analüüsi eriväljaõppe.
English: This is a summary of the European public assessment report (EPAR) for Vizamyl.
Estonian: See on ravimi Vizamyl Euroopa avaliku hindamisaruande kokkuvõte.
English: Vizamyl can only be obtained with a prescription, and PET scans with Vizamyl should only be requested by doctors experienced in the clinical management of patients with diseases such as Alzheimer's disease and other dementias.
Estonian: Vizamyl on retseptiravim ja Vizamyliga PET-uuringule peab suunama arst, kes on kogenud selliste haigustega (Alzheimeri tõbi ja muud dementsused) patsientide ravis.
English: Ref. EMEA/611497/2008
Estonian: viide EMEA/611497/2008
English: London, 20 November 2008 Doc.
Estonian: London, 20. november 2008 Dok.
English: The disease can lead to loss of vision.
Estonian: Haigus võib põhjustada nägemise kaotust.
English: ‘Vernal' means that it usually occurs in the spring.
Estonian: Vernaalne tähendab, et haigus esineb tavaliselt kevadel.
English: International non-proprietary name (INN): ciclosporin
Estonian: Rahvusvaheline mittekaubanduslik nimetus (INN): tsüklosporiin
English: The Committee also noted that the long-term effectiveness of the medicine had not been investigated.
Estonian: Lisaks märkis komitee, et ravimi pikaaegset efektiivsust ei uuritud.
English: Vernal keratoconjunctivitis is a long-term disease that mainly affects young boys living in warm, dry climates such as Mediterranean countries.
Estonian: Vernaalne keratokonjunktiviit on pikaaegne haigus, mis esineb peamiselt noortel poistel, kes elavad soojas kuivas kliimas, nagu Vahemere piirkonna riikides.
English: The application was at day 175 when the company withdrew.
Estonian: Taotluse menetlemine oli kestnud 175 päeva, kui ettevõte võttis taotluse tagasi.
English: What is Vekacia?
Estonian: Mis on Vekacia?
English: This means that it reduces the activity of the immune system (the body's natural defences).
Estonian: See tähendab, et ravim vähendab immuunsüsteemi (organismi loomulike kaitsemehhanismide) toimimisvõimet.
English: Because ciclosporin has been used for many years, the applicant presented data on experimental models from the scientific literature.
Estonian: Kuna tsüklosporiini on kasutatud mitmeid aastaid, esitas müügiloa taotleja katsemudelite andmed teaduslikust kirjandusest.
English: Vekacia was designated as an orphan medicinal product on 6 April 2006.
Estonian: Vekacia nimetati harvikravimiks 6. aprillil 2006.
English: Ciclosporin has been used since the mid1980s to help prevent rejection in transplant patients (when the immune system attacks the transplanted organ).
Estonian: Tsüklosporiini on kasutatud alates 1980. aastate keskpaigast siiratud elunditega patsientidel äratõukereaktsiooni ennetamiseks (kui immuunsüsteem ründab siirdatud elundit).
English: On 14 November 2008, Novagali Pharma S.A. officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Vekacia, for the treatment of vernal keratoconjunctivitis.
Estonian: 14. novembril 2008 teatas ettevõte Novagali Pharma S.A. ametlikult inimravimite komiteele, et soovib tagasi võtta vernaalse keratokonjunktiviidi raviks ette nähtud ravimi Vekacia müügiloa taotluse.
English: Vekacia is a medicine that contains ciclosporin.
Estonian: Vekacia on ravim, mis sisaldab tsüklosporiini.
English: The patients were treated with Vekacia at a concentration of 0.05% (0.5 mg ciclosporin per millilitre) or of 0.1% (1 mg/ml), or with placebo (dummy eye drops).
Estonian: Patsiente raviti Vekaciaga, mille sisaldus oli 0,05% (0,5 mg tsüklosporiini milliliitri kohta) või 0,1% (1 mg/ml), või platseeboga (näivad silmatilgad): kasutati samu silmatilku, kuid need ei sisaldanud tsüklosporiini.
English: The Committee's concerns related to the way the study was designed, in terms of the choice of the patients treated, how symptoms were measured and the way the study's results were analysed.
Estonian: Komitee ettevaatlikkuse põhjused olid seotud uuringukavaga, ravitud patsientide valikuga, sümptomite hindamismeetodiga ja uuringutulemuste analüüsimise viisiga.
English: The main measure of effectiveness chosen was the change in the symptoms of the disease after four weeks, as scored by the doctor.
Estonian: Efektiivsuse põhinäitajaks oli nelja nädala pärast haigussümptomites toimunud muutused.
English: Therefore, at the time of the withdrawal, the CHMP's view was that a benefit of Vekacia had not been sufficiently demonstrated and any benefits did not outweigh the identified risks.
Estonian: Inimravimite komitee oli tagasivõtmise ajal seepärast arvamusel, et Vekacia kasulikkus ei ole küllaldaselt tõendatud ega ületa tuvastatud riske.
English: In patients with vernal keratoconjunctivitis, ciclosporin given as eye drops was expected to suppress the local immune reactions that trigger inflammation in the conjunctiva and cornea.
Estonian: Eeldati, et vernaalse keratokonjunktiviidiga patsientidel pärsib silmatilkadena kasutatav tsüklosporiin immuunsüsteemi paikseid reaktsioone, mis põhjustavad sidekesta ja sarvkesta põletikku.
English: What are the consequences of the withdrawal for patients undergoing clinical trials or compassionate use programmes with Vekacia?
Estonian: Millised on taotluse tagasivõtmise tagajärjed praegu Vekacia kliinilistes uuringutes või eriloaga kasutamise programmides osalevatele patsientidele?
English: The company informed the CHMP that there are no clinical trials or compassionate use programmes with Vekacia in Europe.
Estonian: Ettevõte teatas inimravimite komiteele, et Vekacia kliinilisi uuringuid ega ravimi eriloaga kasutamise programme Euroopas praegu ei toimu.
English: This is inflammation of the conjunctiva (the membrane that lines the eyelid) and the cornea (the transparent layer in front of the pupil), which is caused by allergy.
Estonian: See on sidekesta (silmalaugude sisepinda kattev kest) ja sarvkesta (läbipaistev kiht silma eesosas) põletik, mida põhjustab allergia.
English: Symptoms that were looked at included: burning, itching, pain, sticky eyelids, the sensation of a foreign body in the eyes or photophobia (oversensitivity of the eyes to light).
Estonian: Uuritavate sümptomite hulka kuulusid põletustunne, sügelus, valu, silmalaugude kleepumistunne, silmas oleva võõrkeha aisting ja valguspelgus (silmade ülitundlikkus valguse suhtes).
English: Based on the review of the data and the company's response to the CHMP list of questions, at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Vekacia could not have been approved for the treatment of vernal keratoconjunctivitis.
Estonian: Tuginedes esitatud andmete analüüsile ja ettevõtte vastustele inimravimite komitee esitatud küsimustele, nägi inimravimite komitee taotluse tagasivõtmise ajal põhjust ettevaatlikkuseks ning oli esialgsel seisukohal, et Vekacia kasutamist vernaalse keratokonjunktiviidiga patsientide raviks ei ole võimalik heaks kiita.
English: Vekacia was expected to be used to treat vernal keratoconjunctivitis.
Estonian: Vekaciat kavatseti kasutada vernaalse keratokonjunktiviidi raviks.
English: How is Vekacia expected to work?
Estonian: Milline on Vekacia eeldatav toime?
English: What was Vekacia expected to be used for?
Estonian: Milleks kavatseti Vekaciat kasutada?
English: To support the use of Vekacia in vernal keratoconjunctivitis, the company presented the results of one study in 118 children (over the age of four years) and adolescents.
Estonian: Vekacia kasutamise toetamiseks vernaalse keratokonjunktiviidi ravis esitas ettevõte ühe uuringu tulemused.
English: Questions and answers on the withdrawal of the marketing application for Vekacia
Estonian: Teave müügiloa taotluse tagasivõtmise kohta Vekacia
English: The CHMP had concerns that the effectiveness of Vekacia had not been shown when compared to the vehicle.
Estonian: Inimravimite komitee arvas, et Vekacia võrdlemisel näivate silmatilkadega ei olnud ravimi efektiivsus tõendatud.
English: The active substance in Vekacia, ciclosporin, is an immunosuppressant.
Estonian: Vekacias toimeainena sisalduv tsüklosporiin on immunosupressant (immuunvastust vähendav aine).
English: Not all strengths may be available in every country.
Estonian: Kõikides riikides ei turustata kõiki tugevusi.
English: Econor (valnemulin)
Estonian: Econor (valnemuliin)
English: This overview was last updated in September 2018.
Estonian: Kokkuvõtte viimane uuendus: 09-2018.
English: The European Medicines Agency decided that Econor's benefits are greater than its risks and it can be authorised for use in the EU.
Estonian: Euroopa Ravimiamet otsustas, et Econori kasulikkus on suurem kui sellega kaasnevad riskid ja et ravimi kasutamise saab Euroopa Liidus heaks kiita.
English: Further information on Econor can be found on the Agency's website: ema.europa.eu/medicines/veterinary/EPARs/Econor.
Estonian: Lisateave Econori kohta on ameti veebilehel: ema.europa.eu/medicines/veterinary/EPARs/Econor.
English: Econor received a marketing authorisation valid throughout the European Union on 12 March 1999.
Estonian: Econori müügiluba, mis kehtib kogu ELis, anti 12. märtsil 1999.
English: Other information about Econor
Estonian: Muu teave Econori kohta
English: It works by blocking the production of proteins inside the bacteria and thereby stopping their growth.
Estonian: See toimib, blokeerides valkude teket bakterites ja peatades seeläbi nende kasvu.
English: Econor had a positive effect in terms of reducing the severity of disease and improving its outcome.
Estonian: Econoril oli positiivne mõju, sest see vähendas haiguse raskust ja parandas ravitulemust.
English: What is Econor and what is it used for?
Estonian: Mis on Econor ja milleks seda kasutatakse?
English: However, infection with Mycoplasma hyopneumoniae was not eliminated.
Estonian: Bakteri Mycoplasma hyopneumoniae nakkust siiski täielikult ei likvideeritud.
English: People known to be allergic to valnemulin should use Econor with caution.
Estonian: Inimesed, kes on teadaolevalt valnemuliini suhtes allergilised, peavad olema Econori kasutamisel ettevaatlikud.
English: Econor is an antibiotic.
Estonian: Econor on antibiootikum.
English: What are the risks associated with Econor?
Estonian: Mis riskid Econoriga kaasnevad?
English: In pigs, serious adverse drug reactions following the use of Econor are mainly associated with breeds and cross breeds of Danish and/or Swedish Landrace.
Estonian: Econori kasutamisel sigadel esinenud raskeid kõrvalnähte seostatakse põhiliselt taani ja/või rootsi maatõugude ja ristandtõugudega.
English: Econor is available as a premix for medicated feeding stuff for pigs (10% and 50%) and rabbits (10%), and as an oral powder for pigs (10%).
Estonian: Econori turustatakse ravimsööda eelseguna sigade (10% ja 50%) ja küülikute (10%) jaoks ning sigade suukaudse pulbrina (10%).
English: Econor improves the health and reduces weight loss of the treated pigs, but may not completely eliminate the bacteria that cause lung infection.
Estonian: Econor parandab sigade terviseseisundit ja suurendab kehakaalu, kuid ei pruugi täielikult hävitada kopsunakkust põhjustanud baktereid.
English: The withdrawal period is the time required after administration of the medicine and before the animal can be slaughtered and the meat used for human consumption.
Estonian: Keeluaeg on alates ravimi manustamisest arvestatav aeg, mille jooksul ei tohi looma tappa ega tema liha inimtoiduks tarvitada.
English: Tympanism (distension of the abdomen) is more frequent in rabbits treated with Econor than in untreated rabbits.
Estonian: Tümpanism (kõhu paisumine) esineb sagedamini Econoriga ravitud küülikutel kui ravimata küülikutel.
English: An overview of Econor and why it is authorised in the EU
Estonian: Econori ülevaade ja Euroopa Liidus heakskiitmise põhjused
English: For further information about using Econor, see the package leaflet or contact your veterinarian or pharmacist.
Estonian: Kui vajate Econoriga toimuva ravi kohta lisateavet, lugege palun pakendi infolehte või pöörduge oma veterinaararsti või apteekri poole.
English: Gloves should be worn when handling the product.
Estonian: Ravimi käsitsemisel tuleb kanda kindaid.
English: The withdrawal period for meat and offal from pigs treated with Econor is one day and for meat and offal from rabbits treated with Econor it is ‘zero' days, which means that there is no mandatory waiting time.
Estonian: Econoriga ravitud sigade liha ja söödavate kudede keeluaeg on üks päev ning Econoriga ravitud küülikuliha ja -kudede keeluaeg on null päeva, mis tähendab, et keeluaega ei ole.
English: How does Econor work?
Estonian: Kuidas Econor toimib?
English: Extreme care should, therefore, be taken when using Econor in pigs of Scandinavian origin.
Estonian: Seepärast peab Econori kasutamisel Skandinaavia päritolu sigadel olema eriti ettevaatlik.
English: ERE commonly occurs in commercial rabbit farms during the post-weaning fattening period.
Estonian: Küülikute episootiline enteropaatia esineb tavaliselt küülikufarmides võõrutusjärgsel nuumamisperioodi.
English: In rabbits, Econor is used to reduce mortality during an outbreak of epizootic rabbit enteropathy (ERE).
Estonian: Küülikutel kasutatakse Econori suremuse vähendamiseks küülikute episootilise enteropaatia puhangu ajal.
English: The most common side effects in pigs are pyrexia (high temperature) and a lack of appetite; in severe cases, they might become uncoordinated and remain lying down.
Estonian: Kõige sagedamad kõrvalnähud sigadel on palavik ja isutus, rasketel juhtudel võivad tekkida koordinatsioonihäired ning loomad võivad jääda lamama.
English: If side effects occur, Econor-containing food should be immediately removed; severely affected pigs should be moved to clean, dry pens and given appropriate treatment.
Estonian: Kõrvalnähtude ilmnemisel tuleb kohe eemaldada kogu allesjäänud Econori sisaldav sööt, paigutada raskete kõrvalnähtudega sead puhtasse ja kuiva sulgu ning anda neile sobivat ravi.
English: The active substance of Econor is valnemulin, an antibiotic of the pleuromutilin group.
Estonian: Econori toimeaine on pleuromutiliinide rühma kuuluv antibiootikum valnemuliin.
English: How is Econor used?
Estonian: Kuidas Econori kasutatakse?
English: It is used in pigs to treat or prevent a number of infectious diseases that are caused by bacteria and affect the lungs (i.e. swine enzootic pneumonia) or the gut (i.e. swine dysentery, porcine proliferative enteropathy or porcine colonic spirochaetosis).
Estonian: Seda kasutatakse sigade mitmesuguste bakteriaalsete kopsunakkushaiguste (nt sigade ensootiline pneumoonia) või soolenakkushaiguste (nt sigade düsenteeria või sigade proliferatiivne enteropaatia või sigade käärsoole spirohetoos) ravimiseks või ennetamiseks.
English: Valnemulin is active against a range of bacteria including those responsible for the diseases listed above.
Estonian: Valnemuliin on efektiivne paljude bakterite, sh eelnimetatud haigusi põhjustavate bakterite suhtes.
English: In a study involving 1,152 weaned rabbits, after an outbreak of ERE, treatment with Econor for 21 days reduced mortality during a 4 week period from 23% in untreated rabbits to 11% in those given 20 mg valnemulin per kg of feed, and about 8% in those given 35 mg valnemulin per kg feed.
Estonian: 1152 võõrutatud küüliku uuringus vähendas 21-päevane ravi Econoriga küülikute episootilise enteropaatia puhangu järel suremust 23%-lt (ravimata küülikud) 11%-le küülikutel, kes said 20 mg valnemuliini sööda kg kohta, ja ligikaudu 8%-le neil, kes said 35 mg valnemuliini sööda kg kohta.
English: Econor premix is mixed into pig or rabbit feed by an authorised feed mill and the resulting “medicated feeding stuff” is then distributed to the farmer to treat a large number of pigs or rabbits.
Estonian: Econori eelsegu segatakse seavõi küülikusööda hulka heakskiidetud söödaveskis ning saadav ravimsööt saadetakse sea- või küülikukasvatajale suure arvu loomade ravimiseks.
English: Rabbits must not be given overdoses of Econor as this may disturb gastrointestinal flora (gut bacteria) leading to the development of enterotoxaemia (infection of the gut).
Estonian: Küülikutele ei tohi anda Econori üleannuseid, sest see võib häirida soolefloorat (soolebaktereid), mis põhjustab enterotokseemiat (teatud soolenakkus).
English: If Econor is accidentally consumed by a person, medical advice should be sought immediately and the package leaflet or label shown to the doctor.
Estonian: Econori allaneelamise korral pöörduda viivitamatult arsti poole ja näidata talle ravimi etiketti.
English: What benefits of Econor have been shown in studies?
Estonian: Milles seisneb uuringute põhjal Econori kasulikkus?
English: Econor contains the active substance valnemulin.
Estonian: Econor sisaldab toimeainena valnemuliini.
English: This is a disease associated with changes in the normal balance of bacteria in the gut which allow growth of clostridia, bacteria that produce a toxin which paralyses the intestine.
Estonian: See haigus on seotud normaalse soolefloora häiretega, mis põhjustab klassi Clostridia bakterite vohamist.
English: Econor at a dose of 1 to 1.5 mg valnemulin per kg bodyweight per day (i.e. 25 mg per kg feed) effectively prevented the development of the disease.
Estonian: Econori kasutamine annuses 1-1,5 mg valnemuliini kehamassi kg kohta ööpäevas (söödas 25 mg/kg) ennetas efektiivselt haiguse väljakujunemist.
English: The dose and length of treatment depend on the condition, the animal for which it is being used and its bodyweight.
Estonian: Ravi annus ja kestus sõltuvad nakkusest, ravitava looma liigist ja kehamassist.
English: Some pigs may also suffer oedema (swelling caused by fluid) or erythema (redness) on the hindquarters, and palpebral (eyelid) oedema.
Estonian: Mõnel seal võib tekkida ka ödeem (turse) või erüteem (punetus) tagakehal või lauturse.
English: For treatment of porcine proliferative enteropathy (ileitis), Econor in feed at a dose of 3 to 4 mg valnemulin per kg bodyweight daily (i.e. 75 mg per kg feed) for 10 days improved the clinical condition of the pigs, reduced diarrhoea and reduced weight loss.
Estonian: Econori kasutamisel söödas sigade proliferatiivse enteropaatia (ileiidi) ravimiseks annuses 3-4 mg valnemuliini kehamassi kg kohta ööpäevas (söödas 75 mg/kg) 10 päeva jooksul paranes sigade kliiniline seisund, vähenesid kõhulahtisus ja kaalukaotus.
English: In studies in the treatment and prevention of swine dysentery, Econor in feed at a dose of 3 to 4 mg valnemulin per kg bodyweight daily (i.e. 75 mg per kg feed) for at least 7 days successfully treated swine dysentery.
Estonian: Sigade düsenteeria ravi ja ennetamise uuringutes oli Econor kasutamisel söödas annuses 3-4 mg valnemuliini kehamassi kg kohta ööpäevas (st söödas 75 mg/kg) vähemalt 7 järjestikusel päeval sigade düsenteeria ravimisel efektiivne.
English: In prevention of porcine colonic spirochaetosis (colitis), Econor in feed at a dose of 1 to 1.5 mg valnemulin per kg bodyweight daily (i.e. 25 mg per kg feed) was effective in controlling the clinical signs and prevented weight loss caused by the disease in untreated pigs.
Estonian: Econori kasutamisel söödas sigade käärsoole spirohetoosi (koliidi) ennetamiseks annuses 1-1,5 mg valnemuliini kehamassi kg kohta ööpäevas (söödas 25 mg/kg) paranesid efektiivselt kliinilised nähud ja ennetati kaalukaotust haiguse mõjul, mida esines ravimata sigadel.
English: Direct contact with the skin, mouth and nose should be avoided when mixing Econor and handling the final feed containing the medicine.
Estonian: Econori segamisel ja ravimit sisaldava valmissööda käsitsemisel tuleb vältida sööda sattumist nahale, suhu ja ninna.
English: The oral powder is mixed into pig feed by the pig owner and is used to treat individual pigs.
Estonian: Suukaudse pulbri segab seasööda hulka seakasvataja ja seda kasutatakse üksiksigade raviks.